Holding(s) in Company

Cambridge Antibody Tech Group PLC 18 May 2006 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. Name of shareholder having a major interest GENZYME CORPORATION 3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 AS ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them AS ABOVE 5. Number of shares / amount of stock acquired N/A 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed 380,000 8. Percentage of issued class 0.714% 9. Class of security ORDINARY 10 PENCE SHARES 10. Date of transaction 16 MAY 2006 11. Date company informed 18 MAY 2006 12. Total holding following this notification 4,108,668 13. Total percentage holding of issued class following this notification 7.723% 14. Any additional information NONE 15. Name of contact and telephone number for queries JUSTIN HOSKINS 01223 898589 16. Name and signature of authorised company official responsible for making this notification JUSTIN HOSKINS, COMPANY SECRETARY Date of notification 18 MAY 2006 The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material contained in it, or from any action or decision taken as a result of using this document or any such material. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings